Evidence map›Paper›PMID 32531415›Full record

ArticleJournal of hepatology2020

Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes.

Monika Sarkar, Joshua Grab, Jennifer L Dodge, Erica P Gunderson, Jessica Rubin, Roxanna A Irani, Marcelle Cedars, Norah Terrault

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06682663 (Evaluation of the Effect of Live Streaming Exercise on the Improvement of Hepatic Steatosis and Fibrosis in Pregnant Women with MASLD and Its Study Based on the Liver-gut Axis Mechanism.), which is not on this map. Cited by 83 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 1 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06682663 nanot yet recruitingnot on this mapstarted 2024, after this paper: background citation

Evaluation of the Effect of Live Streaming Exercise on the Improvement of Hepatic Steatosis and Fibrosis in Pregnant Women with MASLD and Its Study Based on the Liver-gut Axis Mechanism.

TypeinterventionalSponsorPeking UniversityRan2024 to 2026Enrolled220ConditionsMetabolic Dysfunction-associated Steatotic Liver DiseaseArmsLive Streaming Exercise
3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 1 synthesis or guideline pooled it, 159 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Increased global burden of metabolic dysfunction-associated steatotic liver disease is also seen in women of reproductive age.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026
    Article
  6. Article
  7. Diminished pleiotrophin as a new clue to pre-eclampsia: Linking impaired angiogenesis to adverse outcomes.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Preexisting Liver Disease and Pregnancy: Optimizing Care to Optimize Outcomes.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2026
    Review
  14. Article
  15. Trimester-Specific Impacts of Steatotic Liver Disease on Adverse Pregnancy Outcomes: A Retrospective Cohort Study.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Monika SarkarDivision of GI/Hepatology, University of California, San Francisco, San Francisco, CA, USA. Electronic address: monika.sarkar@ucsf.edu.
Joshua GrabDepartment of Surgery, University of California, San Francisco, San Francisco, CA, USA.
Jennifer L DodgeDepartment of Surgery, University of California, San Francisco, San Francisco, CA, USA.
Erica P GundersonKaiser Permanente Northern California, Division of Research, Oakland, CA, USA.
Jessica RubinDivision of GI/Hepatology, University of California, San Francisco, San Francisco, CA, USA.
Roxanna A IraniDepartment of Obstetrics and Gynecology, University of California, San Francisco, San Francisco, CA, USA.
Marcelle CedarsDepartment of Obstetrics and Gynecology, University of California, San Francisco, San Francisco, CA, USA.
Norah TerraultDivision of GI and Liver, University of Southern California, Los Angeles, CA, USA.
University of California, San Francisco · USKaiser Permanente · USUniversity of Southern California · US

Funding

UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Holger Willenbring · 1986 to 2026
$30.7M
Androgens and Nonalcoholic Steatohepatitis: The Role of Male Sex Hormones in Women with NASHK23DK111944 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SARKAR, MONIKA · 2017 to 2021
$1.2M
NIDDK NIH HHS K23 DK111944NIDDK NIH HHS P30 DK026743
6 · The paper itself

Abstract

BACKGROUND &

aimsThe prevalence of non-alcoholic fatty liver disease (NAFLD) is rising in young adults, with potential implications for reproductive-aged women. Whether NAFLD during pregnancy confers more serious risks for maternal or perinatal health is unclear.

methodsUsing weighted discharge data from the US national inpatient sample, we evaluated temporal trends of NAFLD in pregnancies after 20 weeks gestation, and compared outcomes to pregnancies with other chronic liver diseases (CLDs) or no CLD. Study outcomes included preterm birth, postpartum hemorrhage, hypertensive complications (pre-eclampsia, eclampsia, and/or hemolysis, elevated liver enzymes, and low platelets syndrome), and maternal or fetal death. NAFLD prevalence was estimated by calendar year and temporal trends tested by linear regression. Outcomes were analyzed by logistic regression adjusted for age, race, multiple gestation, and pre-pregnancy diabetes, obesity, dyslipidemia and hypertension.

resultsAmong 18,574,225 pregnancies, 5,640 had NAFLD and 115,210 had other, non-NAFLD CLD. Pregnancies with NAFLD nearly tripled from 10.5/100,000 pregnancies in 2007 to 28.9/100,000 in 2015 (p <0.001). Compared to the other groups, patients with NAFLD during pregnancy more frequently experienced gestational diabetes (7-8% vs. 23%), hypertensive complications (4% vs. 16%), postpartum hemorrhage (3-5% vs. 6%), and preterm birth (5-7% vs. 9%), all p values ≤0.01. On adjusted analysis, compared to no CLD, NAFLD was associated with hypertensive complications, preterm birth, postpartum hemorrhage and possibly maternal (but not fetal) death.

conclusionThe prevalence of NAFLD in pregnancy has nearly tripled in the last decade and is independently associated with hypertensive complications, postpartum hemorrhage and preterm birth. NAFLD should be considered a high-risk obstetric condition, with clinical implications for pre-conception counseling and pregnancy care. LAY SUMMARY: The prevalence of non-alcoholic fatty liver disease (NAFLD) in pregnancy has almost tripled over the past 10 years. Having NAFLD during pregnancy increases risks for both the mother and the baby, including hypertensive complications of pregnancy, bleeding after delivery, and preterm birth. Thus, pre-conception counseling is warranted with consideration of high-risk obstetric management among women with NAFLD in pregnancy.

Indexed as

Fetal DeathAdultComorbidityDiabetes, GestationalEclampsiaFemaleGestational AgeHumansInfant, NewbornMaternal MortalityNon-alcoholic Fatty Liver DiseasePostpartum HemorrhagePre-EclampsiaPregnancyPremature BirthPrevalenceChronic liver diseaseComplicationsNon-alcoholic steatohepatitisReproductive health

Identifiers

PMID32531415
PMCPMC7438303
OpenAlexW3034888360

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.